卵巣がんにおけるカッププロトーシスに関連する遺伝子シグネチャの定義によるCDKN2Aの関与
Beilei Zhang1, Zhaojie Yang2, Yinuo Zheng1
1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, Shaanxi, China.
Journal of Cancer
|August 27, 2025
まとめ
銅を含むプログラム細胞死の一種であるクプロプトーシスは,卵巣がんにおいて研究されました. 研究者は,患者リスクと治療標的を特定するために,クプロプトーシス関連遺伝子 (CRG) を使用して予測モデルを開発しました.
科学分野:
- 腫瘍学
- 細胞死 研究
- 生物化学
背景:
- クープロプトーシスは,銅の代謝とトリカルボキシル酸 (TCA) サイクルに関連したプログラム細胞死経路です.
- 卵巣がんは依然として重要な健康問題であり,新しい治療戦略が必要である.
- 卵巣がんにおけるクプロプトーシスの役割を理解すれば 新しい治療法が見つかるかもしれません
研究 の 目的:
- クプロプトーシス関連遺伝子 (CRG) に基づく卵巣がんの予測モデルを開発する.
- 卵巣がんの進行と治療への反応におけるクプロプトーシスの機能的役割を調査する.
- 卵巣がんにおける重要なCRGと関連する分子経路を特定する.
主な方法:
- クプロプトーシスに関連する11の遺伝子 (CRG) のスクリーニングにより,卵巣がん患者を異なるリスクグループに分けます.
- 年齢とFIGO段階を含む予後要因を特定するための単項コックス回帰分析.
- 濃縮分析とタンパク質相互作用 (PPI) ネットワーク構築により,分子経路と重要な遺伝子を明らかにする.
- クープロプトーシス誘導と癌細胞および腫瘍に対する効果を評価するために,CuET剤を用いたin vitroおよびin vivo機能測定法.
主要な成果:
- 11つのCRGを用いた予後モデルが構築され,10つの遺伝子は生存率と有意に相関しており,高い予測精度を示しています.
- 特に65歳以上の患者では,年齢とFIGO進行段階 (IIIA- IV) がリスク増加と関連していました.
- 薬物の代謝,組織発育,チロシン,レチノール代謝の経路を強調した.
- CDKN2Aは,PPIネットワークの重要な遺伝子として特定されました.
- CuET治療によるクプロプトーシスの誘導は,CDKN2A発現の増加とともに,卵巣がん細胞の生存,移動,侵入,および異種移植腫瘍の成長を著しく抑制しました.
結論:
- 差異的に表現されたCRGは,卵巣がんの生物学と予後に関する貴重な洞察を提供します.
- 開発された予後モデルは,患者の生存を予測する優れた能力を示しています.
- 特にCDKN2Aを含むクプロプトーシス誘導は,卵巣がんの潜在的な治療戦略です.
関連する概念動画
Inhibition of Cdk Activity
4.9K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
The Retinoblastoma Gene
4.2K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
Cancer-Critical Genes II: Tumor Suppressor Genes
8.0K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.0K
M-Cdk Drives Transition Into Mitosis
5.7K
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
5.7K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Positive Regulator Molecules
5.7K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
5.7K


